John Allen Clements | Academic Influence

John Allen Clements's AcademicInfluence.com Rankings

John Allen Clements

Computer Science

#4292

World Rank

#4517

Historical Rank

#1439

USA Rank

Database

#1773

World Rank

#1858

Historical Rank

#446

USA Rank

computer-science Degrees

Download Badge

Computer Science

John Allen Clements's Degrees

Masters Computer Science Stanford University

Similar Degrees You Can Earn

Best Online Master's in Computer Science

Why Is John Allen Clements Influential?

(Suggest an Edit or Addition)

According to Wikipedia, John Allen Clements is a physician known for his role in the study of pulmonary surfactant. He graduated from Weill Cornell Medical College in 1947. He is a professor at University of California, San Francisco.

(See a Problem?)

John Allen Clements's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Processing of tumour necrosis factor-α precursor by metalloproteinases (1994) (904)
Isolation of disaturated phosphatidylcholine with osmium tetroxide. (1976) (689)
The TIMP2 Membrane Type 1 Metalloproteinase “Receptor” Regulates the Concentration and Efficient Activation of Progelatinase A (1998) (627)
Surface Tension of Lung Extracts (1957) (528)
Surface active materials from dog lung. II. Composition and physiological correlations. (1972) (499)
Processing of tumour necrosis factor-alpha precursor by metalloproteinases. (1994) (430)
Altered surfactant homeostasis and alveolar type II cell morphology in mice lacking surfactant protein D. (1998) (417)
Metabolism and turnover of lung surfactant. (1987) (405)
Kinetics of acetaminophen absorption and gastric emptying in man (1978) (366)
Nucleotide and amino acid sequences of pulmonary surfactant protein SP 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption. (1987) (338)
Assessment of the risk of the respiratory-distress syndrome by a rapid test for surfactant in amniotic fluid. (1972) (334)
Pulmonary surface tension and alveolar stability. (1961) (322)
Alveolar lining layer is thin and continuous: low-temperature scanning electron microscopy of rat lung. (1995) (292)
Composition of surface-active material isolated from beef lung. (1961) (292)
Matrix metalloproteinases, tumor necrosis factor and multiple sclerosis: an overview (1997) (286)
Surfactant apoprotein Mr = 26,000-36,000 enhances uptake of liposomes by type II cells. (1987) (280)
NEONATAL PULMONARY ISCHEMIA Part I: Clinical and Physiological Studies (1967) (279)
Pulmonary surface tension and the mucus lining of the lungs: some theoretical considerations. (1958) (249)
Subfractionation of lung surfactant. Implications for metabolism and surface activity. (1983) (234)
Isolation of apoproteins from canine surface active material. (1973) (226)
Inhibition of matrix metalloproteinases and tumour necrosis factor alpha converting enzyme as adjuvant therapy in pneumococcal meningitis. (2001) (223)
Alveolar Epithelial Cell Mitochondria as Source of the Surface-Active Lung Lining (1962) (220)
Matrix metalloproteinase expression during experimental autoimmune encephalomyelitis and effects of a combined matrix metalloproteinase and tumour necrosis factor-α inhibitor (1997) (215)
Antibiotic Activity and Characterization of BB-3497, a Novel Peptide Deformylase Inhibitor (2001) (204)
Direct determination of surface tension in the lung. (1976) (197)
Pulmonary surfactant therapy. (1995) (197)
Matrix metalloproteinase expression in an experimentally-induced DTH model of multiple sclerosis in the rat CNS (1998) (192)
Pulmonary surfactant and its apoproteins. (1990) (192)
Crystal structure of an integrin-binding fragment of vascular cell adhesion molecule-1 at 1.8 Å resolution (1995) (189)
Ontogeny of tracheal fluid, pulmonary surfactant, and plasma corticoids in the fetal lamb. (1975) (189)
Enhanced expression of MMP-7 and MMP-9 in demyelinating multiple sclerosis lesions (1997) (185)
Surface active materials from dog lung. I. Method of isolation. (1972) (177)
Matrix metalloproteinase-9 and -7 are regulated in experimental autoimmune encephalomyelitis. (1998) (173)
Pulmonary surface film stability and composition. (1979) (163)
Antibacterial Activities and Characterization of Novel Inhibitors of LpxC (2002) (159)
Pulmonary surface tension. (1959) (156)
Stromelysin-1 (Matrix Metalloproteinase-3) and Tissue Inhibitor of Metalloproteinase-3 Are Overexpressed in the Wall of Abdominal Aortic Aneurysms (2002) (150)
Control of lung surfactant by ventilation, adrenergic mediators, and prostaglandins in the rabbit. (2015) (150)
Low molecular weight human pulmonary surfactant protein (SP5): isolation, characterization, and cDNA and amino acid sequences. (1987) (149)
Lung surfactant and neonatal respiratory distress syndrome. (1998) (147)
Surfactant release in excised rat lung is stimulated by air inflation. (1981) (143)
Ventilatory and cholinergic control of pulmonary surfactant in the rabbit. (1977) (139)
Integrin alpha 4 beta 1-mediated melanoma cell adhesion and migration on vascular cell adhesion molecule-1 (VCAM-1) and the alternatively spliced IIICS region of fibronectin. (1994) (137)
Identification of MMP-18, a putative novel human matrix metalloproteinase. (1996) (135)
Alveolar subphase pH in the lungs of anesthetized rabbits. (1981) (133)
PRELIMINARY REPORT. THE PULMONARY HYPOPERFUSION SYNDROME. (1965) (133)
Structure of canine pulmonary surfactant apoprotein: cDNA and complete amino acid sequence. (1985) (132)
Tracheal fluid in fetal lambs: spontaneous decrease prior to birth. (1979) (130)
Functions of the alveolar lining. (2015) (129)
Pulmonary Surfactant and Evolution of the Lungs (1970) (127)
Rates of replacement of lecithins and alveolar instability in rat lungs. (1967) (122)
Macrophage-inflammatory protein protects multipotent hematopoietic cells from the cytotoxic effects of hydroxyurea in vivo. (1992) (120)
Direct determination of volume- and time-dependence of alveolar surface tension in excised lungs. (1978) (116)
Identification of a key integrin-binding sequence in VCAM-1 homologous to the LDV active site in fibronectin. (1994) (115)
Surfactant in the lung and tracheal fluid of the fetal lamb and acceleration of its appearance by dexamethasone. (1975) (106)
Initial clinical trial of EXOSURF, a protein-free synthetic surfactant, for the prophylaxis and early treatment of hyaline membrane disease. (1991) (103)
Precursor-product relationship between rabbit type II cell lamellar bodies and alveolar surface-active material. Surfactant turnover time. (1981) (103)
Differential expression of matrix metalloproteinases in bacterial meningitis. (1999) (102)
Expression of specific matrix metalloproteinases in inflammatory myopathies. (2001) (101)
Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. (1999) (98)
Pulmonary edema and permeability of alveolar membranes. (1961) (96)
Surfactant Apoprotein A Modifies the Inhibitory Effect of Plasma Proteins on Surfactant Activity In Vivo (1995) (95)
Effects of a protein-free, synthetic surfactant on survival and pulmonary function in preterm lambs. (1985) (95)
Competitive binding of vascular cell adhesion molecule-1 and the HepII/IIICS domain of fibronectin to the integrin alpha 4 beta 1. (1994) (92)
Nonionic polymers reverse inactivation of surfactant by meconium and other substances. (1999) (91)
Comparison of captive and pulsating bubble surfactometers with use of lung surfactants. (1994) (89)
Protein composition of rabbit alveolar surfactant subfractions. (1984) (89)
Surface active materials from dog lung. 3. Thermal analysis. (1972) (89)
Effective treatment of models of multiple sclerosis by matrix metalloproteinase inhibitors (1998) (87)
Matrix metalloproteinase expression during experimental autoimmune neuritis. (1998) (87)
Distinct binding specificities of integrins α4β7 (LPAM-1), α4β1 (VLA-4), and αIELβ7 (1994) (86)
Lung surfactant proteins, SP-B and SP-C, alter the thermodynamic properties of phospholipid membranes: a differential calorimetry study. (1993) (86)
Head-tilt method of oral resuscitation. (1960) (86)
Phosphatidylglycerol-deficient lung surfactant has normal properties. (1983) (82)
Lung function in prematurely delivered rabbits treated with a synthetic surfactant. (1987) (80)
Pulmonary and Circulatory Effects of Fibrinopeptides (1967) (80)
Prepartum maturation of the lung in fetal sheep: relation to cortisol. (1981) (80)
Quantitation of matrix metalloproteinases in cultured rat astrocytes using the polymerase chain reaction with a multi‐competitor cDNA standard (1996) (78)
Efficiency of translation initiation by non-AUG codons in Saccharomyces cerevisiae (1988) (77)
Lung surfactant: a personal perspective. (1997) (76)
Ventilation enhances pulmonary alveolar clearance of radioactive dipalmitoyl phosphatidylcholine in liposomes. (1980) (75)
Mechanism of compliance change in excised rat lungs at low transpulmonary pressure. (1970) (72)
Lung volume in the newborn infant. (1962) (72)
Oxygen and carbon dioxide exchange and energy cost of expired air resuscitation. (1958) (72)
Polymer-surfactant treatment of meconium-induced acute lung injury. (2000) (71)
Neonatal pulmonary ischemia. I. Clinical and physiological studies. (1967) (70)
Uptake of lung surfactant subfractions into lamellar bodies of adult rabbit lungs. (1986) (69)
Surface activity of rabbit pulmonary surfactant subfractions at different concentrations in a captive bubble. (1994) (68)
PULMONARY SURFACE TENSION IN EXPERIMENTAL ATELECTASIS. (1964) (68)
The radioimmunoassay of pulmonary surface active material in sheep lung. (2015) (67)
Isolation and properties of type II alveolar cells from rat lung. (1977) (62)
NEONATAL PULMONARY ISCHEMIA (1967) (61)
mRNA sequences influencing translation and the selection of AUG initiator codons in the yeast Saccharomyces cerevisiae (1996) (60)
Transcription and processing signals in the 3-phosphoglycerate kinase (PGK) gene from Aspergillus nidulans. (1986) (60)
Evaluation of pressure-driven captive bubble surfactometer. (1994) (59)
Cellular uptake and processing of surfactant lipids and apoprotein SP-A by rat lung. (1989) (58)
Studies of the structure of lung surfactant protein SP-A. (1989) (58)
Pulmonary surface tension and alveolar stability. (1961) (57)
Association between receptor density, cellular activation, and transformation of adhesive behavior of flowing lymphocytes binding to VCAM‐1 (1997) (57)
Estimation of pulmonary resistance by repetitive interruption of airflow. (1959) (57)
In vitro antibacterial activity of the peptide deformylase inhibitor BB-83698. (2004) (55)
Hyaluronan Decreases Surfactant Inactivation In Vitro (2005) (55)
Stimulation of breathing movements in fetal sheep by inhibitors of prostaglandin synthesis. (1979) (54)
Secretion of human epidermal growth factor from Saccharomyces cerevisiae using synthetic leader sequences. (1991) (54)
Pharmacokinetics in Animals and Humans of a First-in-Class Peptide Deformylase Inhibitor (2004) (52)
Hyaluronan Reduces Surfactant Inhibition and Improves Rat Lung Function after Meconium Injury (2005) (51)
Biological and structural properties of MIP-1 alpha expressed in yeast. (1992) (50)
Two PDGF‐B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation. (1991) (50)
Comparative lipid chemistry of lungs. (1971) (47)
Polyethylene glycol/surfactant mixtures improve lung function after HCl and endotoxin lung injuries. (2001) (47)
Surface tension in the lungs. (1962) (46)
Effective treatment of models of multiple sclerosis with matrix metalloproteinase inhibitors (1998) (46)
Activation dependent and independent VLA-4 binding sites on vascular cell adhesion molecule-1. (1994) (45)
Changes in phospholipid composition of lung surfactant during development in the fetal lamb. (1983) (45)
Correlation of Mechanical Properties of Infant Lungs with Surface Activity of Extracts.∗ (1962) (41)
Coagulation-dependent mechanisms and asthma. (2004) (40)
Changes in quantity, composition, and surface activity of alveolar surfactant at birth. (1987) (39)
Sequence analysis and transformation by the catabolic 3-dehydroquinase (QUTE) gene from Aspergillus nidulans. (1986) (35)
Surface phenomena in relation to pulmonary function. (1962) (35)
Acetaminophen absorption and metabolism in celiac disease and Crohn's disease (1981) (35)
Dispersal of Rabbit Lung into Individual Viable Cells: A New Model for the Study of Lung Metabolism (1972) (33)
SURFACTANT IN PULMONARY DISEASE. (1965) (33)
Synthesis and expression of genes encoding tuna, pigeon, and horse cytochromes c in the yeast Saccharomyces cerevisiae. (1991) (33)
Prolonged transgene expression in rodent lung cells. (1992) (32)
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1' side chain. (2003) (31)
Isolation and identification of type 2 alveolar epithelial cells. (1975) (30)
Reduction of excitotoxicity and associated leukocyte recruitment by a broad‐spectrum matrix metalloproteinase inhibitor (2004) (29)
Pulmonary maturation in the hypophysectomised ovine fetus. Differential responses to adrenocorticotrophin and cortisol. (1981) (29)
Novel approaches to antimicrobial therapy: peptide deformylase. (2002) (28)
Alveolar Surface Tension and Lung Surfactant (2011) (28)
Structure-activity relationships of the peptide deformylase inhibitor BB-3497: modification of the metal binding group. (2002) (28)
Peptide Deformylase Inhibitors, Potential for a New Class of Broad Spectrum Antibacterials (2002) (27)
Lung function, surfactant apoprotein content, and level of PEEP in prematurely delivered rabbits. (1994) (26)
Inhibitors of prostaglandin synthesis, tracheal fluid, and surfactant in fetal lambs. (1981) (26)
Effect of lung collapse on alveolar surfactant in rabbits subjected to unilateral pneumothorax. (1989) (26)
Distinct binding specificities of integrins alpha 4 beta 7 (LPAM-1), alpha 4 beta 1 (VLA-4), and alpha IEL beta 7. (1994) (24)
Cloning and characterization of a gene encoding pig epidermal growth factor. (1991) (23)
Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains. (2003) (23)
Oral anti-pneumococcal activity and pharmacokinetic profiling of a novel peptide deformylase inhibitor. (2004) (21)
Uptake of pulmonary surfactant protein C into adult rat lung lamellar bodies. (1993) (20)
Surfactant secretion and clearance in the newborn. (1989) (19)
Separation by gel chromatography of naturally occurring phosphatidylcholine mixtures according to number of ethylenic linkages. (1970) (19)
Expression and activity of a gene encoding rat cytochrome c in the yeast Saccharomyces cerevisiae. (1989) (19)
Radioimmunoassay of pulmonary surface-active material in the tracheal fluid of the fetal lamb. (2015) (18)
Polyethylene Glycol-Surfactant for Lavage Lung Injury in Rats (2005) (18)
Smoking and pulmonary surfactant. (1972) (17)
Peptide deformylase inhibitors with activity against respiratory tract pathogens. (2004) (17)
Molecular cloning of the 3-phosphoglycerate kinase (PGK) gene from Aspergillus nidulans (2004) (16)
Antenatal prediction of graduated risk of hyaline membrane disease by amniotic fluid foam test for surfactant. (1979) (15)
NO2 interfacial transfer is reduced by phospholipid monolayers. (2001) (14)
Secretion and Clearance of Lung Surfactant: A Brief Review1 (1981) (14)
Urinary levels of substance P and its metabolites are not increased in interstitial cystitis (2001) (14)
An uncommon phosphatidylcholine specific for surface-active material in canine lung. (1973) (12)
Polyethylene Glycol (PEG) Results in Concentration-Dependent Sedimentation of Survanta and Improvement of Its Function (1999) (12)
Association of surfactant protein C with isolated alveolar type II cells. (1995) (10)
The Role of Messenger RNA Sequences and Structures in Eukaryotic Translation (1987) (10)
Generation of Human Umbilical Vein Endothelial Cell Lines Which Maintain Their Differentiated Phenotype (1994) (10)
Expression of active horseradish peroxidase in Saccharomyces cerevisiae. (1992) (10)
Amino acid residues required for binding of vascular cell adhesion molecule-1 to integrin alpha 4 beta 7. (1997) (9)
Crystallization and preliminary X-ray diffraction characterisation of both a native and selenomethionyl VLA-4 binding fragment of VCAM-1. (1994) (9)
Transfer of phospholipids by a protein fraction obtained from canine pulmonary lavage. (1988) (9)
Lipid Synthesis and Surfactant Turnover in the Lungs (1985) (9)
Hyaluronan with dextran added to therapeutic lung surfactants improves effectiveness in vitro and in vivo (2013) (9)
Isolation and Properties of Type II Alveolar Cells from Rat Lung1, 2 (2015) (8)
ESTIMATION OF PULMONARY RESISTANCE BY REPETITIVE INTERRUPTION OF AIRFLOW (1961) (8)
Turnover of Lung Surfactant1 (1984) (8)
Determination of isoprenaline by ion-pair high-pressure liquid chromatography (1980) (7)
The role of yeast mRNA sequences and structures in translation. (1989) (7)
Matrix Metalloproteinases Exhibit Different Expression Patterns in Inflammatory Demyelinating Diseases of the Central and Peripheral Nervous System (1999) (7)
Acute effects of pulmonary artery occlusion on the pool of alveolar surfactant. (1981) (6)
Lung Surface Tension and Surfactant: The Early Years (1996) (5)
Exogenous surfactant for human lung disease. Current status. (1983) (5)
PRELIMINARY REPORT (1965) (4)
Artificial respiration for the nerve gas casualty. (1956) (4)
Characterization of the structure and conformation of platelet-derived growth factor-BB (PDGF-BB) and proteinase-resistant mutants of PDGF-BB expressed in Saccharomyces cerevisiae. (1992) (3)
A pressure plethysmograph with a pneumatic differentiator for pulmonary capillary flow measurements. (1969) (3)
The Alveolar Lining Layer (2008) (3)
Matrix metalloproteinase expression in a rat model of experimental autoimmune neuritis (1997) (2)
Some Relationships Among Structure, Composition, and Functional Characteristics of Lung Surfactant (1987) (2)
ONTOGENY OF TRACHEAL FLUID, PULMONARY SURFACTANT AND PLASMA CORTISOL IN THE FETAL LAMB (1974) (2)
Surfactant protein group with molecular weights 28,000 to 36,000 daltons (SP 28-36) increases the association of phospholipids with freshly isolated type II cells (1986) (2)
Polyethylene Glycol (PEG) Enhances Surfactant Treatment of Acute Lung Injury from Meconium (1999) (2)
Biochemical aspects of pulmonary function. Introductory remarks. (1974) (1)
Expression and characterisation of a very-late antigen-4 (alpha 4 beta 1) integrin-binding fragment of vascular cell-adhesion molecule-1. (1994) (1)
CONTROLLED TRIAL OF A PROTEIN-FREE SYNTHETIC SURFACTANT IN PRETERM RABBITS (1984) (1)
Lung surfactant: an alternate hypothesis. (1971) (1)
Hydroxamic acid derivatives as antibacterial drug (1999) (1)
Structural Features of mRNA that Affect Translation in Yeast (1988) (1)
Pulmonary surfactant: an engineering marvel (1999) (1)
Amino acid residues required for binding of vascular cell adhesion molecule-1 to integrin α 4 β 7 (1997) (0)
COMPARISON OF THE PHARMACOKINETICS OF INTRAVENOUS AND ORAL PROPRANOLOL IN OBESE AND NORMAL VOLUNTEERS (1985) (0)
Intraalveolar Metabolism of Lung Surfactant (1990) (0)
1188 INTERCOSTAL RETRACTOMETER FOR ESTIMATION OF INTRA-PLEURAL PRESSURE (1978) (0)
The influence of surface tension kinetics on lung pressure volume relations (1990) (0)
Molecular characterization of the 3-phosphoglycerate kinase gene from Aspergillus nidulans. (1986) (0)
An intercostal retractometer for estimation of intrapleural pressure changes in infants. (1982) (0)
Study Of The Effects Of Tube Size, Food Supply, And Volume Of Medium On The Autogamy Rate Of Paramecium Aurelia, Variety I, Strain 51.7 K (1952) (0)
PULMONARY AND CARDIOVASCULAR EFFECTS OF A TOTALLY SYNTHETIC, PROTEINFREE SURFACTANT IN PRETERM LAMBS (1984) (0)
Enhanced expression of matrilysin and 92 kDa gelatinase in demyelinating multiple sclerosis lesions (1997) (0)
Nucleotide and amino acid sequences of pulmonary surfactant protein SE 18 and evidence for cooperation between SP 18 and SP 28-36 in surfactant lipid adsorption (lung/lipid-protein interactions/proteolipid) (2016) (0)
The Interrelationships of Pulmonary Surface Tension, Ventilation, and Circulation. (1962) (0)
Lung Surfactant: Its Contribution to Lung Distensibility (1973) (0)
Surfactant Kinetics in the Newborn Rabbit (1990) (0)
Activation State of Α4β1 Integrin Controls Capture, Immobilization and Migration of Flowing Lymphocytes on Purified VCAM-1 (1998) (0)
Synthetic metalloproteinase inhibitors block the processing of Pro-TNFα in vitro and in vivo (1994) (0)
Separation by gel chromatography of naturally incorporates suitable precursors into a lecithin fraction occurring phosphatidylcholine mixtures according to number of ethylenic linkages (2002) (0)
Different expression patterns of matrix metalloproteinases in inflammatory demyelinating diseases of the central and peripheral nervous system (1998) (0)
Lung surfactant: present status and future prospects. (1973) (0)
CRYSTAL STRUCTURE OF E.COLI POLYPEPTIDE DEFORMYLASE COMPLEXED WITH THE INHIBITOR BB-3497 (2001) (0)
1367 PRECURSOR-PRODUCT(PP) RELATIONSHIP BETWEEN RABBIT TYPE II CELL LAMELLAR BODIES(LB) AND ALVEOLAR SURFACE ACTIVE MATERIAL(SAM) AND SAM TURNOVER TIME (1981) (0)
THE CRYSTAL STRUCTURE OF E.COLI PEPTIDE DEFORMYLASE COMPLEXED WITH ACTINONIN (2001) (0)
Letters to the Editor (1965) (0)
F127. Vascular cell adhesion molecule (VCAM-1) can mediate rolling and stationary adhesion of flowing lymphocytes (1995) (0)
Pulmonary surfactant. (1970) (0)
Intraalveolar metabolism of lung surfactant: role of SP-A in regulating surfactant pool size (1990) (0)
Structure-Function Relationships in Lung Surfactant1 (1987) (0)
COMPARISON OF VENTILATION OF A HIGH RESISTANCE-LOW COMPLIANCE PNEUMATIC SYSTEM (GAS CASUALTY MODEL) BY MOUTH-TO-MASK IN-SUFFLATION AND BY A PORTABLE HAND BELLOWS (1954) (0)
Oral ketamine (1984) (0)
Exogenous Surfactant for Human Lung Disease (2015) (0)
Adhesion molecules in disease: vascular cell adhesion molecule-1 as a target for therapy (1996) (0)

This paper list is powered by the following services:

Other Resources About John Allen Clements

en.wikipedia.org

What Schools Are Affiliated With John Allen Clements?

John Allen Clements is affiliated with the following schools: